{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T08:22:06Z","timestamp":1791015726447,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaapos.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of American Association for Pediatric Ophthalmology and Strabismus"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.jaapos.2022.05.006","type":"journal-article","created":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T22:31:41Z","timestamp":1658183501000},"page":"191.e1-191.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["A comparison of primary laser versus laser after anti\u2013vascular endothelial growth factor for type 1 retinopathy of prematurity"],"prefix":"10.1016","volume":"26","author":[{"given":"Juliann E.","family":"Lajoie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard R.","family":"Pacheco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virali","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate A.","family":"Tauber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gil","family":"Binenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard P.","family":"Barry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaapos.2022.05.006_bib1","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-3061","volume":"142","author":"Fierson","year":"2018","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaapos.2022.05.006_bib2","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1001\/archopht.121.12.1684","article-title":"Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial","volume":"121","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jaapos.2022.05.006_bib3","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1007374","article-title":"Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity","volume":"364","author":"Mintz-Hittner","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaapos.2022.05.006_bib4","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/S0140-6736(19)31344-3","article-title":"Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial","volume":"394","author":"Stahl","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jaapos.2022.05.006_bib5","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.ophtha.2020.12.028","article-title":"G-ROP Study Group. Retinal detachment after treatment of retinopathy of prematurity with laser versus intravitreal anti\u2013vascular endothelial growth factor","volume":"128","author":"Barry","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaapos.2022.05.006_bib6","article-title":"Short-term retinal detachment risk after treatment of type 1 retinopathy of prematurity with laser photocoagulation versus intravitreal bevacizumab","volume":"23","author":"Barry","year":"2019","journal-title":"J\u00a0AAPOS"},{"key":"10.1016\/j.jaapos.2022.05.006_bib7","article-title":"Aggressive posterior retinopathy of prematurity in two cohorts of patients in South India: implications for primary, secondary, and tertiary prevention","volume":"23","author":"Shah","year":"2019","journal-title":"J\u00a0AAPOS"},{"key":"10.1016\/j.jaapos.2022.05.006_bib8","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S2352-4642(21)00195-4","article-title":"2-year outcomes of ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW extension study): prospective follow-up of an open label, randomised controlled trial","volume":"5","author":"Marlow","year":"2021","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.jaapos.2022.05.006_bib9","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ajo.2021.11.015","article-title":"Real-world visual outcomes of laser and anti-VEGF treatments for retinopathy of prematurity","volume":"238","author":"Gundlach","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jaapos.2022.05.006_bib10","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.ophtha.2016.04.028","article-title":"Clinical management of recurrent retinopathy of prematurity after intravitreal bevacizumab monotherapy","volume":"123","author":"Mintz-Hittner","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaapos.2022.05.006_bib11","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1001\/archophthalmol.2012.592","article-title":"Reactivation of retinopathy of prematurity after bevacizumab injection","volume":"130","author":"Hu","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jaapos.2022.05.006_bib12","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3928\/23258160-20200702-05","article-title":"SAFER-ROP: updated protocol for anti-VEGF injections for retinopathy of prematurity","volume":"51","author":"Beck","year":"2020","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"10.1016\/j.jaapos.2022.05.006_bib13","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/IAE.0000000000001125","article-title":"Outcomes after laser versus combined laser and bevacizumab treatment for type 1 retinopathy of prematurity in zone I","volume":"37","author":"Yoon","year":"2017","journal-title":"Retina"},{"key":"10.1016\/j.jaapos.2022.05.006_bib14","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1097\/IAE.0000000000001581","article-title":"Prophylactic peripheral laser and fluorescein angiography after bevacizumab for retinopathy of prematurity","volume":"38","author":"Garcia Gonzalez","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.jaapos.2022.05.006_bib15","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/ICB.0000000000000794","article-title":"Short-term computer-assisted quantification of plus disease after treatment of type 1 retinopathy of with intravitreal bevacizumab or retinal laser photocoagulation","volume":"15","author":"Cabrera","year":"2021","journal-title":"Retin Cases Brief Rep"},{"key":"10.1016\/j.jaapos.2022.05.006_bib16","first-page":"365","article-title":"Treatment of type I ROP with intravitreal bevacizumab or laser photocoagulation according to retinal zone","volume":"101","author":"Mueller","year":"2017","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jaapos.2022.05.006_bib17","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1007\/s00417-010-1375-0","article-title":"Effects of intravitreal bevacizumab and laser in retinopathy of prematurity therapy on the development of peripheral retinal vessels","volume":"248","author":"Lee","year":"2010","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jaapos.2022.05.006_bib18","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.jcjo.2020.05.017","article-title":"Fluorescein angiographic features post-intravitreal bevacizumab for retinopathy of prematurity: can they support rescue laser photocoagulation to the avascular retina","volume":"55","author":"Gonzalez","year":"2020","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.jaapos.2022.05.006_bib19","first-page":"296","article-title":"The effectiveness of policy changes designed to increase the attendance rate for outpatient retinopathy of prematurity (ROP) screening examinations","volume":"17","author":"Barry","year":"2013","journal-title":"J\u00a0AAPOS"},{"key":"10.1016\/j.jaapos.2022.05.006_bib20","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.oret.2020.06.002","article-title":"A\u00a0comparison of respiratory outcomes after treating retinopathy of prematurity with laser photocoagulation or intravitreal bevacizumab","volume":"4","author":"Barry","year":"2020","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.jaapos.2022.05.006_bib21","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.survophthal.2021.02.012","article-title":"Neurodevelopmental outcomes in preterm infants with retinopathy of prematurity","volume":"66","author":"Tan","year":"2021","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.jaapos.2022.05.006_bib22","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3928\/01913913-20210316-01","article-title":"Comparison of outcomes between combined sparing laser photocoagulation and intravitreal bevacizumab treatment versus conventional laser photocoagulation in aggressive posterior retinopathy of prematurity","volume":"58","author":"Ittarat","year":"2021","journal-title":"J\u00a0Pediatr Ophthalmol Strabismus"}],"container-title":["Journal of American Association for Pediatric Ophthalmology and Strabismus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091853122001379?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091853122001379?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:26:36Z","timestamp":1761078396000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1091853122001379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S1091853122001379"],"URL":"https:\/\/doi.org\/10.1016\/j.jaapos.2022.05.006","relation":{},"ISSN":["1091-8531"],"issn-type":[{"value":"1091-8531","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A comparison of primary laser versus laser after anti\u2013vascular endothelial growth factor for type 1 retinopathy of prematurity","name":"articletitle","label":"Article Title"},{"value":"Journal of American Association for Pediatric Ophthalmology and Strabismus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaapos.2022.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Association for Pediatric Ophthalmology and Strabismus. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}